Miloš Brkušanin is an assistant professor and a research associate at the University of Belgrade-Faculty of Biology, specializing in human molecular genetics with a focus on inherited neuromuscular diseases. Over the past decade, he has made significant contributions to the development of molecular diagnostic procedures for spinal muscular atrophy (SMA), transforming the diagnostic landscape in Serbia. Miloš led a pioneering feasibility study for SMA newborn screening, which laid the foundation for the national screening program he now oversees. His research also explores the use of biomarkers to assess the effectiveness of innovative genetic therapies for SMA. Through his work, Miloš is not only advancing scientific knowledge, but also improving clinical outcomes for patients, while inspiring future scientists through his teaching and global conference presentations.